| Lower humoral and cellular immunity following asymptomatic SARS-CoV-2 infection compared to symptomatic infection in education (the ACE cohort) G Hopkins, N Gomez, D Tucis, L Bartlett, G Steers, E Burns, M Brown, ... Journal of Clinical Immunology 44 (6), 147, 2024 | | 2024 |
| Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid BA Krishna, EY Lim, M Metaxaki, S Jackson, L Mactavous, ... Science Advances 10 (8), eadi9379, 2024 | 11 | 2024 |
| Lower Humoral and Cellular Immunity following Asymptomatic SARS-CoV-2 Infection in Education (The ACE Cohort) G Hopkins, N Gomez, D Tucis, L Bartlett, G Steers, E Burns, M Brown, ... | | 2024 |
| Repression of the major immediate early promoter of human cytomegalovirus allows transcription from an alternate promoter R Mason, E Bradley, M Wills, J Sinclair, M Reeves Journal of General Virology 104 (9), 001894, 2023 | 1 | 2023 |
| O7 Antibody-mediated delivery of plasma membrane tethered recombinant TAPBPR enables highly efficient exchange of HBV peptides across a wide range of HLA class I allotypes R Sinharay, A Neerincx, A Altenburg, J Bauer, MR Wills, JS Walz, ... Gut 72 (Suppl 3), A6-A6, 2023 | | 2023 |
| Long COVID: what is known and what gaps need to be addressed B Krishna, M Wills, N Sithole British Medical Bulletin 147 (1), 6, 2023 | 7 | 2023 |
| Cytomegalovirus and Cardiovascular Disease: A Hypothetical Role for Viral G-Protein-Coupled Receptors in Hypertension GF Bomfim, F Priviero, E Poole, RC Tostes, JH Sinclair, D Stamou, ... American Journal of Hypertension 36 (9), 471-480, 2023 | 3 | 2023 |
| Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly IATM Ferreira, CYC Lee, WS Foster, A Abdullahi, LM Dratva, ZK Tuong, ... Cell Reports 42 (8), 2023 | 9 | 2023 |
| Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity M Potts, A Fletcher-Etherington, K Nightingale, F Mescia, L Bergamaschi, ... Cell Reports 42 (6), 2023 | 4 | 2023 |
| Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor MR Perera, EJD Greenwood, TWM Crozier, EG Elder, J Schmitt, ... The Journal of infectious diseases 227 (4), 543-553, 2023 | 13 | 2023 |
| Reduced incidence of long coronavirus disease referrals to the Cambridge University teaching hospital long coronavirus disease clinic BA Krishna, M Metaxaki, MR Wills, N Sithole Clinical Infectious Diseases 76 (4), 738-740, 2023 | 8 | 2023 |
| Antibody-mediated delivery of TAPBPR enables the redirection of virus-specific T cell responses to tumour cells A Neerincx, A Aflalo, I Hafstrand, AA Torres, A McDowall, A Altenburg, ... | 1 | 2022 |
| HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites EL Davies, M Noor, EY Lim, CJ Houldcroft, G Okecha, C Atkinson, ... Frontiers in Immunology 13, 1083230, 2022 | 3 | 2022 |
| IL-10-Secreting CD8+ T Cells Specific for Human Cytomegalovirus (HCMV): Generation, Maintenance and Phenotype SE Jackson, GX Sedikides, V Romashova, G Okecha, ... Pathogens 11 (12), 1530, 2022 | 4 | 2022 |
| Antiviral activity of Cytomegalovirus-specific CD4+ T cells against lytically infected non-haemopoietic cells EY Lim, CJ Houldcroft, SE Jackson, G Okecha, M Wills bioRxiv, 2022.12. 08.519485, 2022 | | 2022 |
| Proteomic analysis of circulating immune cells identifies novel cellular phenotypes associated with COVID-19 severity M Potts, A Fletcher-Etherington, K Nightingale, F Mescia, L Bergamaschi, ... medRxiv, 2022.11. 16.22282338, 2022 | | 2022 |
| Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly IATM Ferreira, CYC Lee, W Foster, A Abdullahi, ZK Tuong, BJ Stewart, ... medRxiv, 2022.10. 13.22281024, 2022 | 2 | 2022 |
| O02 Discovery of novel HLA class I presented hepatitis B peptides using an immunopeptidomics approach R Sinharay, A Neerincx, A Altenburg, J Bauer, MR Wills, JS Walz, ... Gut 71 (Suppl 3), A2-A2, 2022 | | 2022 |
| P16 TAPBPR shapes the hepatitis B immunopeptidome presented on HLA class I molecules R Sinharay, A Neerincx, A Altenburg, J Bauer, MR Wills, JS Walz, ... Gut 71 (Suppl 3), A42-A43, 2022 | | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies (vol 593, pg 136, 2021) DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... NATURE 608 (7922), E24-E24, 2022 | | 2022 |
